Literature DB >> 20730317

Caspase-3 and Bcl-2 expression in glioblastoma: an immunohistochemical study.

Luís Fernando Tirapelli1, Paulo Henrique Nasser Andre Bolini, Daniela Pretti da Cunha Tirapelli, Fernanda Maris Peria, Aline Nazareth Paixão Becker, Fabiano Pinto Saggioro, Carlos Gilberto Carlotti.   

Abstract

The unfavorable prognosis of malignant gliomas can also be explained by the incomplete knowledge of their molecular pathways. Studies regarding the regulatory process of apoptosis in glioblastoma (GBM), the most common malignant glioma, are few, and better knowledge of the expression of pro and anti-apoptotic proteins could collaborate with the development of new treatments founded on molecular basis. The objective of this study was to evaluate by immunohistochemistry the expression of caspase-3 and Bcl-2 in 30 samples of GBMs. The expression of caspase-3 (mean 17.67%) was lower than Bcl-2 (mean 30.92%), a statistically significant result (p<0.0001), suggesting low apoptotic activity in these tumors. Other studies of proteins related to the intrinsic and extrinsic pathway of apoptosis are required to provide additional information of this mechanism in GBMs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20730317     DOI: 10.1590/s0004-282x2010000400023

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  10 in total

Review 1.  TLR-4 Signaling vs. Immune Checkpoints, miRNAs Molecules, Cancer Stem Cells, and Wingless-Signaling Interplay in Glioblastoma Multiforme-Future Perspectives.

Authors:  Jakub Litak; Cezary Grochowski; Joanna Litak; Ida Osuchowska; Krzysztof Gosik; Elżbieta Radzikowska; Piotr Kamieniak; Jacek Rolinski
Journal:  Int J Mol Sci       Date:  2020-04-28       Impact factor: 5.923

2.  Procaspase-3 Overexpression in Cancer: A Paradoxical Observation with Therapeutic Potential.

Authors:  Matthew W Boudreau; Jessie Peh; Paul J Hergenrother
Journal:  ACS Chem Biol       Date:  2019-07-16       Impact factor: 5.100

3.  Predicting transition from oral pre-malignancy to malignancy via Bcl-2 immuno-expression: Evidence and lacunae.

Authors:  Ruby Dwivedi; Shaleen Chandra; Divya Mehrotra; Vineet Raj; Rahul Pandey
Journal:  J Oral Biol Craniofac Res       Date:  2020-07-19

4.  An integer linear programming approach for finding deregulated subgraphs in regulatory networks.

Authors:  Christina Backes; Alexander Rurainski; Gunnar W Klau; Oliver Müller; Daniel Stöckel; Andreas Gerasch; Jan Küntzer; Daniela Maisel; Nicole Ludwig; Matthias Hein; Andreas Keller; Helmut Burtscher; Michael Kaufmann; Eckart Meese; Hans-Peter Lenhof
Journal:  Nucleic Acids Res       Date:  2011-12-30       Impact factor: 16.971

5.  The Bcl-2 inhibitor Obatoclax overcomes resistance to histone deacetylase inhibitors SAHA and LBH589 as radiosensitizers in patient-derived glioblastoma stem-like cells.

Authors:  Lotte M E Berghauser Pont; Jochem K H Spoor; Subramanian Venkatesan; Sigrid Swagemakers; Jenneke J Kloezeman; Clemens M F Dirven; Peter J van der Spek; Martine L M Lamfers; Sieger Leenstra
Journal:  Genes Cancer       Date:  2014-11

6.  The effect of silver nanoparticles (AgNPs) on proliferation and apoptosis of in ovo cultured glioblastoma multiforme (GBM) cells.

Authors:  Kaja Urbańska; Beata Pająk; Arkadiusz Orzechowski; Justyna Sokołowska; Marta Grodzik; Ewa Sawosz; Maciej Szmidt; Paweł Sysa
Journal:  Nanoscale Res Lett       Date:  2015-03-01       Impact factor: 4.703

Review 7.  Post-Transcriptional Modifications of RNA as Regulators of Apoptosis in Glioblastoma.

Authors:  Anton Dome; Maya Dymova; Vladimir Richter; Grigory Stepanov
Journal:  Int J Mol Sci       Date:  2022-08-17       Impact factor: 6.208

8.  Glioblastoma Proximity to the Lateral Ventricle Alters Neurogenic Cell Populations of the Subventricular Zone.

Authors:  Luisina B Ripari; Emily S Norton; Raquel Bodoque-Villar; Stephanie Jeanneret; Montserrat Lara-Velazquez; Anna Carrano; Natanael Zarco; Carla A Vazquez-Ramos; Alfredo Quiñones-Hinojosa; Carlos de la Rosa-Prieto; Hugo Guerrero-Cázares
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 5.738

9.  Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patients.

Authors:  Avadhut D Joshi; Rachel C Botham; Lisa J Schlein; Howard S Roth; Antonella Mangraviti; Alexandra Borodovsky; Betty Tyler; Steve Joslyn; Jayme S Looper; Michael Podell; Timothy M Fan; Paul J Hergenrother; Gregory J Riggins
Journal:  Oncotarget       Date:  2017-07-07

10.  TLR-4/Wnt modulation as new therapeutic strategy in the treatment of glioblastomas.

Authors:  Giovanna Casili; Maria Caffo; Michela Campolo; Valeria Barresi; Gerardo Caruso; Salvatore M Cardali; Marika Lanza; Raffaella Mallamace; Alessia Filippone; Alfredo Conti; Antonino Germanò; Salvatore Cuzzocrea; Emanuela Esposito
Journal:  Oncotarget       Date:  2018-12-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.